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Abstract
Background: Detection of Mycobacterium avium subspecies paratuberculosis (MAP) infection is key to the
control of Johne’s disease. Immunohistochemistry is one of the methods of detection of MAP infection in
tissues. However, unavailability of commercial antibodies that can detect the organism is a limiting factor for
the use of immunohistochemistry. This study was aimed at developing an immunohistochemistry method to
diagnose MAP in infected tissues using antibodies against MAP recombinant heat shock protein 70kd.
Results: MAP Heat shock protein 70 gene was amplified and cloned into an expression vector, Champion pET-SUMO,
then expressed in E coli, purified and used to produce polyclonal rabbit antibodies against the Heat shock protein.
Immunohistochemistry was performed in 35 MAP infected tissues with anti-HSP70 polyclonal antibodies. All 35 MAP
infected tissues were positive for MAP within macrophages, epithelioid cells and giant cells either in clumps or singly
as individual bacilli. No positive staining was seen in the three uninfected normal tissues and in MAP infected tissues
where primary antibodies were substituted with PBS or pre-immune serum from the same rabbit.
Conclusion: Anti-HSP70 produced in this study offers an opportunity for improved diagnosis, screening of MAP in
animal tissues and in studies on the pathogenesis of MAP
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Background
Mycobacterium avium subspecies paratuberculosis
(MAP) is the cause of Paratuberculosis or Johne’s disease
in cattle, buffaloes, sheep, goats, deer and other species
[1]. MAP is regarded as a possible zoonotic pathogen
since there are incriminating reports on its involvement
in Crohn’s disease [2, 3]. Diagnosis of paratuberculosis
or MAP infection is key to the control of Johne’s disease
[4, 5]. Confirmatory diagnosis is based on culture,
antigen detection systems and nucleic acid based amplifi-
cations to support gross and microscopic lesions in
suspected cases [6]. In low prevalence areas, these specia-
lised techniques might not be in place, so diagnosis of the
infection may be done on post-mortem and histological
examinations [7]. Unfortunately, in some cases of MAP
infection, the gross and microscopic lesions might not be
well developed and need the support of other techniques
such as Ziehl Neelsen acidfast staining (ZN), PCR, in situ
hybridisation and immunohistochemistry (IHC) [8]. ZN
staining is cheap and easier to perform but its sensitivity
and specificity is low in comparison with the other three
[9]. PCR and in situ hybridisation need special equipment
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which are lacking in many laboratories; whereas IHC,
though technically simpler, is limited by the unavailability
of specific commercial antibodies against the pathogen.
Thus there is continuing search for new antigens and
antibodies for use in IHC detection of MAP [10]. Recom-
binant DNA technology offers an opportunity to produce
large quantities of antigens which are difficult to purify in
sufficient quantities in their wild forms [11]. Therefore,
finding new antigens and use of recombinant DNA
technology are the best hope for immunodiagnostic of
paratuberculosis as it is for many other diseases.
Heat shock proteins are antigenic proteins that can
initiate immune responses, deliver antigens into major
histocompatibility complex I (MHCI) pathways, elicit
pro-inflammatory responses in antigen presenting cells
and facilitate folding and unfolding of cytosolic proteins
[12, 13]. They are produced in different molecular
weights by almost all kinds of cells in response to cell
stress but each of them is different from the other [14];
hence they can be considered as markers of the cells or
organisms that produce them [14]. Small heat shock
proteins are therapeutic because of their chaperone
activity [15]. Heat shock protein 70 (HSP70) of myco-
bacteria are antigenic, stimulating immune response
against mycobacteria [16]. One study [17] showed that
MAP HSP70 could be an effective subunit vaccine
against MAP. This is via the stimulation of dendritic
cells and a strong T-helper 1 cell response [18, 19].
HSP70 fusion protein is particularly strongly antigenic
[18]. HSP70 and other chaperonin genes are also potential
drug targets [20]. Differential expression of HSP65 and
HSP70 during different stages of paratuberculosis has
been reported [21], suggesting that they might act as
markers of different stages of infection and the type of
disease [22]. When epitope specificities of Ig G antibodies
were compared to HSP60/65 in healthy individuals and
patients with Chronic heart disease and inflammatory
disease [23], it was found that the epitopes varied specifi-
cally in different diseases at different stages, providing
more evidence that HSP70 antibodies can be markers of
disease progression.
Many studies have attempted to determine the potential
use of heat shock proteins for immunodiagnosis with
various successes. For instance, one of the molecules from
HSP70 family for Typanosoma cruzi was able to distin-
guish between infected and non-infected persons and
between treated and non-treated persons [24]. That
finding is supported by another study [25]. Although the
use of HSP70 from MAP in serological diagnosis has
been explored [10], there is hardly any report on IHC
using antibodies against MAP HSP70 in naturally
infected cattle.
The purpose of this study was to evaluate antibodies
against recombinant MAP HSP70 expressed in Champion
PET-SUMO expression system for IHC diagnosis of MAP
in infected tissues.
Method
The gene for heat shock protein 70 was amplified as
follows: Primers ehsp70f (5′-GGG GTA CCC CCT ATG
GCT CGT GCG GTC GGT ATC-3′) and ehsp70r (5′-
CCC AAG CTT GGG TCA CTT GGA CTC CCG GTC
ATC G-3′) were designed in frame with the initiation
codon of SUMO protein in Champion PET-SUMO
vector (Invitrogen, Life technology). HSP70 gene was
amplified from DNA extracted from a Ugandan isolate of
MAP. The set up included 50μl PCR reaction containing
5μl of custom master mix, 5μl of forward and reverse
primers each, 35μl of PCR water, 0.5μl of Taq polymerase
and 2μl of DNA template. The thermal profiles of the
reaction consisted of initial denaturation at 94°C for 5
min, 35 cycles of denaturation at 94°C for 30 s, 63°C for
60 s, 72°C for 120 s, and a final extension of 72°C for 10
min. The reaction was cooled to 4°C and then removed.
The success of the PCR reaction was analysed using 1%
agarose electrophoresis. The PCR product was then
ligated into the expression vector Champion PET-SUMO
according to the manufacturer’s instructions. The ligation
product was transformed into Mach1 T1 cells. Successful
transformation was confirmed by restriction endonuclease
digestion using AflII(New England biolabs) and PCR. After
confirmation, the recombinant plasmid in the correct
orientation was transformed into BL21 D3 cells. The
plasmid containing SUMO+ CAT (chlorophenical acetyl
transaminase) was used as a control for the expression.
Expression of the protein was done according to the man-
ufacturer’s instruction and was confirmed on SDS-PAGE
stained with Coomasie blue and Western blot then probed
with anti-His antibodies. HSP70 was purified under native
conditions as a fusion to SUMO protein using Pro-Bond
Ni-NTA agarose protein purification system (Invitrogen,
Life technologies incorporated) according to the manufac-
turer’s instruction manual. The SUMO fusion tag was
removed from the HSP70 using SUMO protease digestion.
Fractions of the digested protein were pooled together
and concentrated using amicon® ultra centrifugal filter
columns of 50 Kd. The purity of the protein was checked
through SDS PAGE analysis. The protein was then consti-
tuted with a storage buffer containing 50mM Tris-HCl
(pH 7.9), 0.1mM EDTA, 0.1mM DTT, 50% glycerol and
0.1M NaCl (TGED +0.1M NaCl). Five hundred millilitres
of the solution containing 350μg of HSP70 was emulsified
with an equal volume of Aluminium hydroxide adjuvant
(alhydrogel®, Brenntag Biosector, Fredriksund, Denmark).
Two New Zealand white rabbits were each injected with
1ml of the emulsified HSP70 at about 4 -5 sites over the
suprascapular region. Another rabbit was used as control
and immunised with sterile phosphate buffered saline
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emulsified with the adjuvant alone, while two others were
immunised with whole cell suspensions of killed MAP
isolates. Boosting of immune response was done with 150
μg of the protein on 14th and 28th days after initial vac-
cination. The control rabbit received the same treatment
as before (PBS and adjuvant, cell suspension plus
adjuvant) each time during the boosting. The rabbits were
bled on the 10th and 24th days after immunisation and
terminal bleeding was done on the 42nd day of the experi-
ment. To confirm the production of polyclonal antibodies,
western blot was performed to probe the antigens.
For Immunohistochemical staining of MAP using anti-
bodies against HSP70 and whole cell suspensions; 5
micrometre thick sections were cut on Poly L Lysine
coated slides and IHC was carried out as described by
Ramos-Vara and Miller [26] with a few modifications.
Antigen retrieval was carried out using citrate buffer
treatment at pH 6.2. For the antigen retrieval, Di-
Sodium citrate buffer (pH 6.2) was preheated for 10 min
in a microwave oven set at 1000W; the microwave oven
was adjusted to 700W then a rack containing the slides
was immersed into the buffer and heated for 20 min.
The beaker containing the buffer plus the slides were
Fig. 1 An agarose gel electrophoresis of HSP70 gene amplified product and restriction analysis of PET-SUMO + HSP70 recombinant plasmid. a
The open reading frame of HSP70 gene, 1872bp in length was amplified. The PCR product in a was later cloned in PET-SUMO vector (Invitrogen).
b The restriction patterns of HSP70 cloned in frame with PET-SUMO vector. From left, lane 1 is the DNA ladder, lanes 2 is a recombinant with the
gene in a 3’-5’direction (wrong orientation) showing two bands 6720bpand 910bp, lane 3 and 4 are non-recombinant plasmids without the
insert(≈5643bp), lane 5 is the plasmid with an insert in the correct 5’-3’ orientationshowing two fragments 6445bp and 1185bp. The DNA ladder
used is the NEB 1kb ladder. The bar chart to the left of A shows the sizes of the DNA fragments on the ladder, which in turn shows the size of
the amplified products in gel a and b
Fig. 2 An SDS-PAGE gel analysis showing the expression of HSP70
before and four hours post induction plus the purified fusion
protein. Lane 1 is a protein standard, lane 2 is pre-induction whole
cell lysate, lane 3 is a whole cell lysate after 4 h post induction, lane
4 is the pellet after the cells were lysed under native conditions, lane
5 is the supernatant under native conditions, lane 6 is the purified
HSP70 with the SUMO protein tag while lane 7 shows HSP70 after
the SUMO fusion tag was removed with SUMO protease. The fusion
protein was 83 Kd before the SUMO tag was removed (lane 6) by a
sumo protease, resulting in a pure HSP70 recombinant protein of 70
Kd (lane 7)
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removed and allowed to cool for 20 min. The slides were
then washed three times. 100μl of normal goat serum
was used for blocking for 30 min at room temperature
(RT) followed by the addition of 100μl of antiHSP70
antibodies (1/1000) and antibodies against whole cell
suspensions (1/250). The sections were incubated at 4°C
overnight. Pre-immune rabbit serum was used as a nega-
tive control instead of the primary antibodies (1/1000).
Secondary goat anti-rabbit antibodies coupled to
horseradish peroxidase was used at a dilution of 1/800
and sections were incubated at RT for one hour. DAB
(3, 3, diaminobenzidine) solution was prepared from
Sigma FastTM DAB and urea tablets as described in the
material data sheet. DAB was applied on the tissue for
2-3 min.
Thirty-five histologically positive cases of JD and two
non-MAP tuberculous cases comprising a case of avian
TB and a bovine TB were stained with antibodies against
HSP70. Three cases that were without any granuloma-
tous lesion were also included as controls. Twenty five
of the 35 cases were obtained during a Paratuberculosis
survey in Kampala abattoirs and were found to have
characteristic microscopic lesions as well as staining
positive for Ziehl Niesen stain (See the Additional file 1:
Table S1). Additionally, one case was from a case of
Johne disease confirmed by necropsy, culture and PCR.
The remaining nine cases included intestinal tissue
blocks of 4 cattle and 5 sheep from Germany which was
a kind gift from Prof. Dr. Manfred Reinacher of the
Insitute for Veterinary Pathology, University of Giessen,
Germany (see Additional file 1: Table S1).
Results
The amplification of HSP70 gene resulted into a PCR
product of 1872bp PCR product (Fig. 1a). The restriction
analysis of the PET-SUMO+ HSP70 recombinant plasmid
showed two bands of 6445 base-pairs and 1185bp for the
gene in a correct 5’-3’ orientation; and 6720 base-pairs
and 910 base-pairs with the gene cloned in the opposite
3’-5’ orientation after digestion with AflII (Fig. 1b). When
the recombinant gene was expressed, a band of 83kd was
observed with increasing intensity on SDS-PAGE from 1-
4 h post induction. Optimal expression was observed
between 3 and 4 h post induction. This protein was cut
into a 70kd protein (HSP70) and a 13kd protein (SUMO)
using SUMO protease (Fig. 2). Immunohistochemical
staining with anti-HSP70 polyclonal antibodies showed
positive staining in all 35 MAP infected tissues. MAP was
stained within macrophages, epithelioid cells and giant
cells either in clumps or singly as individual bacilli.
Figure 3 shows specific staining of infected cells in a hea-
vily infected ileocaecal mucosal villus, specifically in the
lamina propria. Most of the infected cells showed a diffuse
staining of the cytoplasm, suggesting that large amounts
of HSP70 were expressed by the bacteria (Figs. 3 and 4).
Positive staining of acid-fast bacteria was also seen in two
tuberculous lesions from avian and bovine TB (Fig. 5).
The acid fast organisms in the avian and bovine tissues
had not been typed and were assumed to be M. avium
and M. bovis respectively. No positive staining was seen in
the three apparently normal tissues and in MAP infected
tissues where primary antibodies were substituted with
PBS or pre-immune serum from the same rabbit. Positive
Fig. 3 Immunohistochemical staining of Mycobacterium avium subsp. paratuberculosis in bovine intestinal mucosa using anti-MAP HSP70
antibodies. a A section through the mucosa showing many macrophages containing mycobacteria staining positive with Anti-HSP70
antibodies (DAB substrate-chromagen, and haematoxylin counter staining). b Higher magnification of a. Macrophages (arrow with long
tail) and epithelioid cells, stained immunohistochemically using anti-HSP70 antibodies. Note the diffuse character of the staining within
the cells. Bar = 17.5μM. c A negative control section in which the Primary antibodies were substituted by pre-immune rabbit serum. No
positive staining was observed (DAB substrate-chromagen, and haematoxylin counter staining). Bar = 140μm
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staining of MAP was also seen with positive control
antibodies raised by immunisation of rabbits with whole
cell suspensions of MAP.
Discussion
Positive staining of MAP was obtained in all infected
tissues. Thus antibodies against MAP HSP70 are sensitive
in the immunohistochemical diagnosis of MAP. The
staining showed both individual bacilli, clumps of bacilli
and diffuse staining within the cytoplasm [10] stated that
HSP70 is a soluble antigen which easily diffuses out of the
mycobacterium. This implies that HSP70 also diffuses out-
side the infected macrophages. Thus antibodies to HSP70
could be used for ELISA, IHC and electron microscopy
[27]. Since there are no commercial antibodies against
MAP available for use at the moment, despite the nume-
rous studies including the ones cited in this paper, the
need to test putative diagnostic antigens is crucial. Immu-
nohistochemistry has been shown to be more sensitive
and specific than ZN staining [28–30]. In this study
HSP70 was expressed as a fusion protein with SUMO pro-
tein (HSP70 + SUMO) unlike in previous studies where it
was produced as Histidine tagged fusion protein [10, 27].
The differences in the type and size of the fusion tag
would be expected to result in different conformational
structure, hence different epitopes. However polyclonal
HSP70 antibodies have not resulted into specific MAP
staining since positive staining was also observed with a
bovine and avian tuberculous lesions though these had
weaker signals than MAP infected tissues. This is not sur-
prising considering the promiscuous character of most
polyclonal antibodies [26]. Cross reactivity of other MAP
antigens with other mycobacteria have been observed
using polyclonal antibodies [28] but there is possibility
that epitope mapping of this protein could unravel specific
epitopes for MAP. Cross reactivity of both polyclonal and
monoclonal antibodies has been reported for other MAP
antigens except for HSP32 subunit which is so far able to
distinguish between MAP and some related mycobacteria
[29]. Despite the cross reactivity of the recombinant
HSP70, this antigen still offers an opportunity for de-
tection of MAP and other mycobacterial infection
using immunohistochemistry in suspicious cases
where a negative ZN stain has resulted. Epitope map-
ping of this recombinant HSP70 is necessary to find
specific monoclonal antibodies for diagnosis of MAP
in different animal tissues.
Conclusion
Anti-HSP70 produced in this study offers an opportunity
for improved diagnosis of MAP in animal tissues. It
could also be used in screening of cases especially in
Fig. 4 Immunohistochemical staining of Mycobacterium avium subspecies paratuberculosis in the mucosal tissue of bovine. The brown areas
stained are areas containing large numbers of macrophages and epithelial cells containing the bacteria
Fig 5 Positive immunohistochemical staining of bovine and avian tuberculous lesions with antibodies against recombinant MAP HSP70. a Bovine
lymph node with bovine tuberculosis. b Chicken spleen with avian tuberculosis. Light brown staining shows macrophages and epithelioid cells
containing tuberculous mycobacteria. Note that in both A and B, the staining is weaker than in the case of MAP infected macrophages. HSP70
antibodies, with DAB substrate-chromagen, and haematoxylin counter staining. Bar = 35μm
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studies focusing on abattoir surveys of MAP infection
particularly if automated IHC protocols are used and in
studies on the pathogenesis of MAP.
Additional file
Additional file 1: Table S1. Information regarding the samples included
in the study. (DOCX 17 kb)
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